Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis

Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 1999-02, Vol.134 (2), p.233-235
Main Authors: Tagher, Robert J., Baumann, Robert, Desai, Nirmala
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Blood Transfusion
Cholinesterase Inhibitors - therapeutic use
Diseases of striated muscles. Neuromuscular diseases
Female
Humans
Immunoglobulins, Intravenous - therapeutic use
Infant, Newborn
Medical sciences
Myasthenia Gravis - therapy
Neostigmine - therapeutic use
Neurology
Pregnancy
Pregnancy Complications - physiopathology
Pregnancy Complications - therapy
Treatment Failure
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3
cites cdi_FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3
container_end_page 235
container_issue 2
container_start_page 233
container_title The Journal of pediatrics
container_volume 134
creator Tagher, Robert J.
Baumann, Robert
Desai, Nirmala
description Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care. (J Pediatr 1999;134:233-5)
doi_str_mv 10.1016/S0022-3476(99)70422-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69567353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347699704221</els_id><sourcerecordid>69567353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3</originalsourceid><addsrcrecordid>eNqFkUFrFTEUhYMo9bX6EwqDiOhi9GYySSYrkWKrUHChrkMmc6emZJKaZArv35vpe1Rw4yqE-53DvecQck7hPQUqPnwH6LqW9VK8VeqdhL7-6BOyo6BkKwbGnpLdI_KcnOZ8CwCqBzghJ0oxypnYEXtpnF8TNnFuXCjJ3GOIa_b7xkyLCy4XTDg1blnWEG98HFfvQiWb8gubktCUBUPZ1AFjMMX4ZtmbXKfBmeam-rn8gjybjc_48viekZ-Xn39cfGmvv119vfh03dqeitJOlneg2MjZ1AmQfAAp7Sz6mY98nsUAApF3gxoHqiRgPVGAsDiySQ28E4adkTcH37sUf6-Yi15ctui9qbutWQvFhWScVfDVP-BtXFOou2mqeslpR2mF-AGyKeaccNZ3yS0m7TUFvTWgHxrQW7xaKf3QgN5050fzdVxwelQdI6_z18e5ydb4OZlgXf5rLgY1DJvNxwOGNbF7h0ln6zBYnFxCW_QU3X8W-QPmAaKs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194751211</pqid></control><display><type>article</type><title>Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis</title><source>ScienceDirect Journals</source><creator>Tagher, Robert J. ; Baumann, Robert ; Desai, Nirmala</creator><creatorcontrib>Tagher, Robert J. ; Baumann, Robert ; Desai, Nirmala</creatorcontrib><description>Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care. (J Pediatr 1999;134:233-5)</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/S0022-3476(99)70422-1</identifier><identifier>PMID: 9931536</identifier><identifier>CODEN: JOPDAB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Blood Transfusion ; Cholinesterase Inhibitors - therapeutic use ; Diseases of striated muscles. Neuromuscular diseases ; Female ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Infant, Newborn ; Medical sciences ; Myasthenia Gravis - therapy ; Neostigmine - therapeutic use ; Neurology ; Pregnancy ; Pregnancy Complications - physiopathology ; Pregnancy Complications - therapy ; Treatment Failure</subject><ispartof>The Journal of pediatrics, 1999-02, Vol.134 (2), p.233-235</ispartof><rights>1999 Mosby, Inc.</rights><rights>1999 INIST-CNRS</rights><rights>Copyright Mosby-Year Book, Inc. Feb 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3</citedby><cites>FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1689881$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9931536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tagher, Robert J.</creatorcontrib><creatorcontrib>Baumann, Robert</creatorcontrib><creatorcontrib>Desai, Nirmala</creatorcontrib><title>Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care. (J Pediatr 1999;134:233-5)</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood Transfusion</subject><subject>Cholinesterase Inhibitors - therapeutic use</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Medical sciences</subject><subject>Myasthenia Gravis - therapy</subject><subject>Neostigmine - therapeutic use</subject><subject>Neurology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - physiopathology</subject><subject>Pregnancy Complications - therapy</subject><subject>Treatment Failure</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkUFrFTEUhYMo9bX6EwqDiOhi9GYySSYrkWKrUHChrkMmc6emZJKaZArv35vpe1Rw4yqE-53DvecQck7hPQUqPnwH6LqW9VK8VeqdhL7-6BOyo6BkKwbGnpLdI_KcnOZ8CwCqBzghJ0oxypnYEXtpnF8TNnFuXCjJ3GOIa_b7xkyLCy4XTDg1blnWEG98HFfvQiWb8gubktCUBUPZ1AFjMMX4ZtmbXKfBmeam-rn8gjybjc_48viekZ-Xn39cfGmvv119vfh03dqeitJOlneg2MjZ1AmQfAAp7Sz6mY98nsUAApF3gxoHqiRgPVGAsDiySQ28E4adkTcH37sUf6-Yi15ctui9qbutWQvFhWScVfDVP-BtXFOou2mqeslpR2mF-AGyKeaccNZ3yS0m7TUFvTWgHxrQW7xaKf3QgN5050fzdVxwelQdI6_z18e5ydb4OZlgXf5rLgY1DJvNxwOGNbF7h0ln6zBYnFxCW_QU3X8W-QPmAaKs</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Tagher, Robert J.</creator><creator>Baumann, Robert</creator><creator>Desai, Nirmala</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Mosby-Year Book, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19990201</creationdate><title>Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis</title><author>Tagher, Robert J. ; Baumann, Robert ; Desai, Nirmala</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood Transfusion</topic><topic>Cholinesterase Inhibitors - therapeutic use</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Medical sciences</topic><topic>Myasthenia Gravis - therapy</topic><topic>Neostigmine - therapeutic use</topic><topic>Neurology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - physiopathology</topic><topic>Pregnancy Complications - therapy</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tagher, Robert J.</creatorcontrib><creatorcontrib>Baumann, Robert</creatorcontrib><creatorcontrib>Desai, Nirmala</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tagher, Robert J.</au><au>Baumann, Robert</au><au>Desai, Nirmala</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>134</volume><issue>2</issue><spage>233</spage><epage>235</epage><pages>233-235</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><coden>JOPDAB</coden><abstract>Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care. (J Pediatr 1999;134:233-5)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>9931536</pmid><doi>10.1016/S0022-3476(99)70422-1</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 1999-02, Vol.134 (2), p.233-235
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_69567353
source ScienceDirect Journals
subjects Adult
Biological and medical sciences
Blood Transfusion
Cholinesterase Inhibitors - therapeutic use
Diseases of striated muscles. Neuromuscular diseases
Female
Humans
Immunoglobulins, Intravenous - therapeutic use
Infant, Newborn
Medical sciences
Myasthenia Gravis - therapy
Neostigmine - therapeutic use
Neurology
Pregnancy
Pregnancy Complications - physiopathology
Pregnancy Complications - therapy
Treatment Failure
title Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A48%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20of%20intravenously%20administered%20immunoglobulin%20in%20the%20treatment%20of%20neonatal%20myasthenia%20gravis&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Tagher,%20Robert%20J.&rft.date=1999-02-01&rft.volume=134&rft.issue=2&rft.spage=233&rft.epage=235&rft.pages=233-235&rft.issn=0022-3476&rft.eissn=1097-6833&rft.coden=JOPDAB&rft_id=info:doi/10.1016/S0022-3476(99)70422-1&rft_dat=%3Cproquest_cross%3E69567353%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-dc52093b53d260758077cf64f5b5ff6806ee5289b81970e683606ceb3d98526a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=194751211&rft_id=info:pmid/9931536&rfr_iscdi=true